comparemela.com

Latest Breaking News On - Chairman matthew rabinowitz - Page 1 : comparemela.com

Matthew Rabinowitz Sells 1,012 Shares of Natera, Inc (NASDAQ:NTRA) Stock

Natera, Inc. (NASDAQ:NTRA – Get Free Report) Chairman Matthew Rabinowitz sold 1,012 shares of Natera stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $88.36, for a total transaction of $89,420.32. Following the transaction, the chairman now directly owns 1,075,648 shares in the company, valued […]

Osterweis Capital Management Inc Invests $1 66 Million in Natera, Inc (NASDAQ:NTRA)

Osterweis Capital Management Inc. bought a new position in Natera, Inc. (NASDAQ:NTRA – Get Rating) in the 4th quarter, HoldingsChannel reports. The fund bought 41,280 shares of the medical research company’s stock, valued at approximately $1,658,000. Several other hedge funds also recently made changes to their positions in the company. Prelude Capital Management LLC acquired […]

Natera (NASDAQ:NTRA) Price Target Cut to $70 00

Natera (NASDAQ:NTRA – Get Rating) had its target price cut by Piper Sandler from $80.00 to $70.00 in a research report released on Tuesday morning, The Fly reports. Several other brokerages have also recently commented on NTRA. Morgan Stanley boosted their price target on shares of Natera from $70.00 to $72.00 and gave the stock […]

Natera, Inc (NASDAQ:NTRA) Chairman Matthew Rabinowitz Sells 2,484 Shares of Stock

Natera, Inc. (NASDAQ:NTRA – Get Rating) Chairman Matthew Rabinowitz sold 2,484 shares of the business’s stock in a transaction that occurred on Wednesday, March 22nd. The shares were sold at an average price of $56.32, for a total value of $139,898.88. Following the completion of the sale, the chairman now owns 639,803 shares in the […]

Natera, Inc (NASDAQ:NTRA) Receives Consensus Recommendation of Moderate Buy from Analysts

Shares of Natera, Inc. (NASDAQ:NTRA – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average twelve-month price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.